YU7604A - Polimorf soli derivata piridazinona za tretman aritmije - Google Patents

Polimorf soli derivata piridazinona za tretman aritmije

Info

Publication number
YU7604A
YU7604A YU7604A YUP7604A YU7604A YU 7604 A YU7604 A YU 7604A YU 7604 A YU7604 A YU 7604A YU P7604 A YUP7604 A YU P7604A YU 7604 A YU7604 A YU 7604A
Authority
YU
Yugoslavia
Prior art keywords
treatment
arrythmia
pyridazinone derivative
polymorph salt
polymorph
Prior art date
Application number
YU7604A
Other languages
English (en)
Inventor
Nagy Peter Kotay
Gyula Simig
Jozsef Barkoczy
Kirallyi Zsuzsa Szent
Original Assignee
Egis Gyogyszergyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Rt. filed Critical Egis Gyogyszergyar Rt.
Publication of YU7604A publication Critical patent/YU7604A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22—Nitrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Treating Waste Gases (AREA)

Abstract

Pronalazak se odnosi na novi kristalni oblik I 5-hloro-4-[3-[2-(3,4-dimetoksi-fenil)etil]-N-metilamino]-propilamino]-3-[2H]-piridazinon fumarata, postupak za njegovo pripremanje, farmaceutske preparate koji sadrže i upotrebu pomenutog novog polimorfa za tretman aritmije.[The invention relates to the new crystalline form I 5-chloro-4-[3-[N-[2-(3,4-dimethoxy-phenyl)-ethyl]-N-methylamino]-propylamino]-3- [2H]-pyridazinone fumarate, a process for the preparation thereof, pharmaceutical compositions containing the same and the use of said new polymorph for the treatment of arrhythmia.
YU7604A 2001-07-26 2002-07-26 Polimorf soli derivata piridazinona za tretman aritmije YU7604A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0103064A HUP0103064A3 (en) 2001-07-26 2001-07-26 Polymorphic form of 5-chloro-4-(3-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino]-propylamino)-3-(2h)-piridazinone fumarate, its use, process for its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
YU7604A true YU7604A (sh) 2006-08-17

Family

ID=89979563

Family Applications (1)

Application Number Title Priority Date Filing Date
YU7604A YU7604A (sh) 2001-07-26 2002-07-26 Polimorf soli derivata piridazinona za tretman aritmije

Country Status (15)

Country Link
US (1) US20040266772A1 (sh)
EP (1) EP1417179A1 (sh)
JP (1) JP2004536868A (sh)
KR (1) KR20040030861A (sh)
CN (1) CN1545505A (sh)
CA (1) CA2454774A1 (sh)
CZ (1) CZ2004124A3 (sh)
EA (1) EA200400222A1 (sh)
HU (1) HUP0103064A3 (sh)
IL (1) IL159967A0 (sh)
PL (1) PL365483A1 (sh)
SK (1) SK542004A3 (sh)
WO (1) WO2003010150A1 (sh)
YU (1) YU7604A (sh)
ZA (1) ZA200400483B (sh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227181B1 (en) * 2002-09-11 2010-09-28 Egis Gyogyszergyar Nyilvanosan Use of 5-chloro-4-[3-[n-[2-(3,4-dimethoxyphenyl)ethyl)]-n-methylamino]-propylamino]-3-(2h)-pyridazinone for producing pharmaceutical compositions having metabolic modulator effect
HU227115B1 (en) * 2003-10-10 2010-07-28 Egis Gyogyszergyar Nyilvanosan Pellets containing pyridazinone derivative
GB201105537D0 (en) * 2011-03-31 2011-05-18 Vantia Ltd New process

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU214320B (hu) * 1991-12-20 1998-03-02 EGIS Gyógyszergyár Rt. Eljárás új 3(2H)-piridazinon-származékok és ezeket tartalmazó gyógyszerkészítmények előállítására
BR9815967A (pt) * 1998-06-05 2004-06-22 Egyt Gyogyszervegyeszeti Gyar Processo para a preparação de um derivado de amino-5-cloro de 3(2h)-piridazinona-4-substituìdo

Also Published As

Publication number Publication date
US20040266772A1 (en) 2004-12-30
CA2454774A1 (en) 2003-02-06
CN1545505A (zh) 2004-11-10
WO2003010150A1 (en) 2003-02-06
HUP0103064A3 (en) 2005-06-28
HU0103064D0 (en) 2001-10-28
CZ2004124A3 (cs) 2004-06-16
EA200400222A1 (ru) 2004-12-30
IL159967A0 (en) 2004-06-20
KR20040030861A (ko) 2004-04-09
ZA200400483B (en) 2005-04-22
SK542004A3 (en) 2004-08-03
JP2004536868A (ja) 2004-12-09
HUP0103064A2 (hu) 2003-02-28
PL365483A1 (en) 2005-01-10
EP1417179A1 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
JO2371B1 (en) 4-phenyl-pyridine derivatives
MY132473A (en) Crystalline hydrochloride of (r)-(-)-2-<n-[4-(1,1- dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl>-chroman
NZ241194A (en) The pure (-) enantiomer of ((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrozono)propanedinitrile, compositions and new intermediates
GB9416219D0 (en) Receptor ligands
AU2267395A (en) Benzofuran derivatives useful as inhibitors of bone resorption
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
IL160545A0 (en) (-)-1-(3,4-dichlorophenyl) -3- azabicyclo [3.1.0] hexane, compositions thereof and uses as a dopamine-reuptake inhibitor
MY135218A (en) 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases
JO2321B1 (en) 4-phenyl-pyridine derivatives
YU7804A (sh) Stabilni polimorf flibanserina,postupak za njegovo dobijanje u industrijskim razmerama i njegova primena za pripremanje lekova
GB9209769D0 (en) Chemical compounds for use as anti-ischemic medicaments
HUP0003949A2 (hu) Vitronektin receptor antagonisták, valamint a vegyületeket tartalmazó gyógyszerkészítmények
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
HUP0003931A2 (hu) Vitronektin receptor antagonisták, valamint a vegyületeket tartalmazó gyógyszerkészítmények
BG106293A (en) Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
IL128851A (en) Pharmaceutical composition for lowering the uric acid level in the human body
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
YU7604A (sh) Polimorf soli derivata piridazinona za tretman aritmije
CA2462390A1 (en) Anthranilic acid amides and pharmaceutical use thereof
MY133438A (en) Morpholinobenzamide salts
IL112695A (en) Pharmaceutical compositions containing pyridazinone derivatives
JP2003535853A (ja) ２−アミノチアゾリン誘導体およびｎｏ−合成酵素の阻害剤としてのその使用
BR0214780A (pt) Sal de ácido cìtrico de um composto terapêutico e composições farmacêuticas deste
HK1046529A1 (zh) 製備3(2h)-噠嗪酮-4-取代氨基-5-氯-衍生物的方法